Kristian Brock
Kristian Brock
UCB Pharma
Verified email at - Homepage
Cited by
Cited by
Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study
P Hillmen, AC Rawstron, K Brock, S Muñoz-Vicente, FJ Yates, R Bishop, ...
Journal of clinical oncology 37 (30), 2722, 2019
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
G Middleton, K Brock, J Savage, R Mant, Y Summers, J Connibear, ...
The Lancet Respiratory Medicine 8 (9), 895-904, 2020
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open …
SP Bach, A Gilbert, K Brock, S Korsgen, I Geh, J Hill, T Gill, P Hainsworth, ...
The Lancet Gastroenterology & Hepatology 6 (2), 92-105, 2021
How to design a dose-finding study using the continual reassessment method
GM Wheeler, AP Mander, A Bedding, K Brock, V Cornelius, AP Grieve, ...
BMC medical research methodology 19 (1), 1-15, 2019
Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial
SP Mollan, JL Mitchell, RS Ottridge, M Aguiar, A Yiangou, Z Alimajstorovic, ...
JAMA neurology 78 (6), 678-686, 2021
Combination lenalidomide and azacitidine: a novel salvage therapy in patients who relapse after allogeneic stem-cell transplantation for acute myeloid leukemia
C Craddock, D Slade, C De Santo, R Wheat, P Ferguson, A Hodgkinson, ...
Journal of Clinical Oncology 37 (7), 580, 2019
Sustained release of decorin to the surface of the eye enables scarless corneal regeneration
LJ Hill, RJA Moakes, C Vareechon, G Butt, A Ng, K Brock, G Chouhan, ...
NPJ Regenerative medicine 3 (1), 23, 2018
Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension
V Vijay, SP Mollan, JL Mitchell, E Bilton, Z Alimajstorovic, KA Markey, ...
JAMA ophthalmology 138 (12), 1264-1271, 2020
Initial results of ibrutinib plus venetoclax in relapsed, refractory CLL (Bloodwise TAP CLARITY Study): high rates of overall response, complete remission and MRD eradication …
P Hillmen, T Munir, A Rawstron, K Brock, SM Vicente, F Yates, R Bishop, ...
Blood 130, 428, 2017
Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): results of the PePS2 trial
G Middleton, K Brock, Y Summers, J Connibear, R Shah, C Ottensmeier, ...
Annals of Oncology 29, viii497, 2018
Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
SP Mollan, BR Wakerley, Z Alimajstorovic, J Mitchell, R Ottridge, ...
The journal of headache and pain 22 (1), 1-9, 2021
Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the bloodwise TAP clarity study
P Hillmen, A Rawstron, K Brock, SM Vicente, F Yates, R Bishop, ...
Blood 132, 182, 2018
Implementing the EffTox dose-finding design in the Matchpoint trial
K Brock, L Billingham, M Copland, S Siddique, M Sirovica, C Yap
BMC medical research methodology 17 (1), 1-15, 2017
Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
EG Ryan, K Brock, S Gates, D Slade
BMC Medical Research Methodology 20, 1-9, 2020
Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension
SP Mollan, JL Mitchell, A Yiangou, RS Ottridge, Z Alimajstorovic, ...
Neurology 99 (11), e1090-e1099, 2022
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
JL Mitchell, HS Lyons, JK Walker, A Yiangou, O Grech, Z Alimajstorovic, ...
Brain 146 (5), 1821-1830, 2023
FLAG-IDA and ponatinib in patients with blast phase chronic myeloid leukaemia: results from the phase I/II UK trials acceleration programme matchpoint trial
M Copland, D Slade, J Byrne, K Brock, H De Lavallade, C Craddock, ...
Blood 134, 497, 2019
Violet-blue light arrays at 405 nanometers exert enhanced antimicrobial activity for photodisinfection of monomicrobial nosocomial biofilms
FD Halstead, MA Hadis, N Marley, K Brock, MR Milward, PR Cooper, ...
Applied and environmental microbiology 85 (21), e01346-19, 2019
Continued long term responses to ibrutinib+ venetoclax treatment for relapsed/refractory CLL in the blood cancer UK TAP clarity trial
P Hillmen, RH Boucher, N Webster, S Dalal, K Brock, F Yates, ...
Blood 136, 17-18, 2020
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT …
M Copland, D Slade, G McIlroy, G Horne, JL Byrne, K Rothwell, K Brock, ...
The Lancet Haematology 9 (2), e121-e132, 2022
The system can't perform the operation now. Try again later.
Articles 1–20